Previous 10 | Next 10 |
Amarillo Biosciences press release ( NASDAQ: AIMD ): Q3 GAAP EPS of -$0.51. Revenue of $1.75M (+386.1% Y/Y). For further details see: Amarillo Biosciences GAAP EPS of -$0.51, revenue of $1.75M
Ainos Reports Unaudited Third Quarter 2022 Financial Results PR Newswire Revenues increased by 384% year over year Debt ratio decreased to 7% from 75% at year-end 2021 SAN DIEGO , Nov. 7, 2022 /PRNewswire/ -- Ainos, Inc. (NASDAQ: AIMD, AIM...
Five New Drug Candidates Show Promise as Ainos Pursues Licensing Partners of its Low-dose Oral Interferon Formulation PR Newswire The FDA gave positive feedback regarding filing a Biologics License Application (BLA) for Sjögren's syndrome following two Phase 3 stu...
Clinical results thus far have shown low-dose oral interferon's promising efficacy as a new treatment or as an alternative to high-dose injectable interferon SAN DIEGO, CA / ACCESSWIRE / October 31, 2022 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos", or the "Company"), a diversifie...
What You Need to Know About Buying Penny Stocks This Week If you’re looking to make money in the stock market, there’s no better time to start trading penny stocks. Now, it’s important to consider that we have seen an incredible amount of volatility in the stock mar...
How to Trade Penny Stocks For Beginners Penny stocks are a great way to get started in the stock market. They’re relatively low-risk and can offer a high return on investment. However, there are a few things you should know before you start trading penny stocks . First, i...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Pavel Kapysh / Shutterstock Arcimoto (NASDAQ: FUV ) stock is on a wild ride today after the electric vehicle (EV) company revealed plans for a strategic restructuring. According to a filing with the U...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock Ainos (NASDAQ: AIMD ) stock is gaining on Friday after seeing positive results from hamster trials of its Covid-19 treatment. These trials saw the company measuring the effectiveness of V...
Ainos ( NASDAQ: AIMD ) has surged 50% premarket after the company said its low-dose oral interferon ( IFN )-alpha formulation Veldona showed a positive effect on lungs infected with the the Omicron variant of the coronavirus by regulating the immune response, there...
VELDONA® formulation showed significant stabilization of physical condition and complete recovery from lung inflammation throughout the course of treatment period. By upregulation of immunomodulatory, Ainos' VELDONA® formulation demonstrates efficacy against new variant virus ...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States SRIVARU Holding Limited (SVMH) rose 94.8% to $0.2971 on volume of 77,516,058 shares NVIDIA Corporation (NVDA) fell 0.3% to $129.16 on volume of 39,120,242 shares Longeveron Inc. (LGVN) rose 27.0% to $3.415 on volume of 36,214,736 shar...
Clinical trials for AI Nose-powered Ainos Flora device moves forward with 75 meaningful case results, paving the way for next-gen product targeting at-home testing Next-Gen Ainos Flora will advance with NVIDIA CUDA, targeting Q3 for design completion and Q4 for clinical trial kickoff ...
A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) rose 12.4% to $0.0886 on volume of 1,366,648,994 shares Ascent Solar Technologies Inc (ASTI) rose 63.4% to $0.2147 on volume of 656,794,712 shares Pineapple Energy Inc. (PEGY) rose 61.4% to $...